ELIAS Animal Health

Overview
News
Animal Therapeutics?
Product stageSegments
Growth
?
Oncology therapeutics
?

ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Their approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. ELIAS Cancer Immunotherapy (ECI™) harnesses the power of the dog’s own immune system to eliminate the cancer. ECI™ utilizes adoptive cell therapy to deliver an army of activated T cells that kill cancer cells.

HQ location:
10900 S. Clay Blair Blvd Suite 700 Olathe KS USA
Founded year:
2014
Employees:
1-10
IPO status:
Private
Total funding:
USD 13.4 mn
Last Funding:
USD 10.0 mn (Series A; Apr 2024)
Last valuation:
-
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.